Package Leaflet: Information for the User
Telmisartan Teva Pharma 40mg Tablets EFG
Telmisartan
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
5 Storage of Telmisartan Teva Pharma
Telmisartan Teva Pharma belongs to a class of medicines known as angiotensin II receptor antagonists. Angiotensin II is a substance produced in your body which causes your blood vessels to narrow, thus increasing your blood pressure. Telmisartan Teva Pharma blocks the effect of angiotensin II, allowing your blood vessels to relax and your blood pressure to decrease.
Telmisartan Teva Pharma is used to treat essential hypertension (high blood pressure) in adults. "Essential" means that the high blood pressure is not caused by any other condition.
High blood pressure, if left uncontrolled, can lead to damage to your blood vessels and organs, such as the heart, kidneys, and eyes. This can lead to complications such as heart attack, heart failure, kidney failure, stroke, or blindness. Usually, there are no symptoms of high blood pressure before damage occurs. Therefore, it is important to regularly check your blood pressure to ensure it remains within a normal range.
Telmisartan Teva Pharma is also used to reduce cardiovascular events (such as heart attacks or strokes) in patients with a high risk because their blood supply to the heart or legs is reduced or blocked, or they have had a stroke or have a high risk of developing diabetes. Your doctor will inform you if you are at high risk of developing these events.
Do not take Telmisartan Teva Pharma
If any of these apply to you, tell your doctor or pharmacist before taking Telmisartan Teva Pharma.
Warnings and precautions
Tell your doctor if you are suffering from or have ever suffered from any of the following conditions or diseases:
Tell your doctor before taking Telmisartan Teva Pharma:
Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g., potassium) in your blood at regular intervals.
See also information under the heading "Do not take Telmisartan Teva Pharma".
If you think you might be pregnant (or might become pregnant), tell your doctor. Telmisartan Teva Pharma is not recommended during the first trimester of pregnancy and must not be taken after the third month of pregnancy as it may cause serious harm to your baby (see section pregnancy).
If you are going to have surgery or receive anesthesia, inform your doctor that you are taking Telmisartan Teva Pharma.
Telmisartan Teva Pharma may be less effective in lowering blood pressure in black patients.
Children and adolescents
Telmisartan Teva Pharma is not recommended for children and adolescents under 18 years.
Other medicines and Telmisartan Teva Pharma
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Your doctor may need to change the dose of these medicines or take other precautions. In some cases, you may need to stop taking one of the medicines. This is especially true for the following medicines when taken with Telmisartan Teva Pharma:
The effect of Telmisartan Teva Pharma may be reduced when you use non-steroidal anti-inflammatory medicines (e.g., aspirin or ibuprofen) or corticosteroids.
Telmisartan Teva Pharma may increase the blood-lowering effect of other medicines used to treat high blood pressure.
If you have a condition called "orthostatic hypotension" (a drop in blood pressure when standing up from sitting or lying down, resulting in dizziness or fainting), your condition may worsen if you take Telmisartan Teva Pharma in combination with:
Pregnancy and breast-feeding
Pregnancy
Inform your doctor if you think you might be pregnant (or might become pregnant). Your doctor will normally advise you to stop taking Telmisartan Teva Pharma before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Telmisartan Teva Pharma. It is not recommended to take Telmisartan Teva Pharma during the first trimester of pregnancy, and it must not be taken after the third month of pregnancy as it may cause serious harm to your baby.
Breast-feeding
Inform your doctor if you are breast-feeding or plan to breast-feed. Telmisartan Teva Pharma is not recommended for women who are breast-feeding, and your doctor may decide to prescribe a different treatment if you want to breast-feed, especially if you are feeding a newborn or premature baby.
Driving and using machines
Some people may feel dizzy or tired when taking Telmisartan Teva Pharma. If you feel dizzy or tired, do not drive or use machines.
Telmisartan Teva Pharma contains sorbitol
This medicine contains 42.8 mg of sorbitol in each tablet.
Telmisartan Teva Pharma contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
.
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose of Telmisartan Teva is one tablet once daily. Try to take the tablet at the same time each day. You can take Telmisartan Teva Pharma with or without food. The tablets should be swallowed with a little water or another non-alcoholic drink. It is important that you take Telmisartan Teva Pharma every day until your doctor tells you to stop. If you feel that the effect of Telmisartan Teva Pharma is too strong or too weak, talk to your doctor or pharmacist.
For the treatment of high blood pressure, the usual dose of Telmisartan Teva Pharma for most patients is 40 mg once daily to control blood pressure over 24 hours. Your doctor has recommended a lower dose of one 20 mg tablet daily. Alternatively, Telmisartan Teva Pharma can be used in combination with diuretics such as hydrochlorothiazide, which have been shown to have an additive blood pressure-lowering effect with Telmisartan Teva Pharma.
For the reduction of cardiovascular events, the usual dose of Telmisartan Teva is one 80 mg tablet once daily. At the start of treatment with Telmisartan Teva 80 mg, blood pressure should be frequently monitored.
If your liver is not working properly, the usual dose should not exceed 40 mg once daily.
If you take more Telmisartan Teva Pharma than you should
If you accidentally take too many tablets, contact your doctor, pharmacist, or the nearest hospital emergency department immediately.
If you forget to take Telmisartan Teva Pharma
If you forget to take a dose, do not worry. Take it as soon as you remember and then continue as before. If you do not take your tablet on one day, take your normal dose the next day. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious and require immediate medical attention:
If you experience any of the following symptoms, you should contact your doctor immediately:
Sepsis* (often referred to as "blood poisoning", a severe infection that involves an inflammatory response of the whole body), rapid swelling of the skin and mucous membranes (angioedema); these side effects are rare (may affect up to 1 in 1,000 people) but are extremely serious and patients should stop taking the medicine and contact their doctor immediately. If these side effects are not treated, they can be fatal.
Possible side effects of Telmisartan
Common side effects (may affect up to 1 in 10 people):
Low blood pressure (hypotension) in patients treated for cardiovascular events
Uncommon side effects (may affect up to 1 in 100 people):
Urinary tract infections, upper respiratory tract infections (e.g., sore throat, sinusitis, common cold), decreased red blood cell count (anemia), high levels of potassium, difficulty falling asleep (insomnia), feeling sad (depression), fainting (syncope), spinning sensation (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in patients treated for high blood pressure, difficulty breathing, cough, abdominal pain, diarrhea, abdominal discomfort, bloating, vomiting, itching, increased sweating, drug rash, back pain, muscle cramps, muscle pain (myalgia), kidney failure including acute kidney failure, chest pain, and symptoms of weakness and high levels of creatinine in the blood.
Rare side effects (may affect up to 1 in 1,000 people):
Sepsis* (often referred to as "blood poisoning", a severe infection that involves an inflammatory response of the whole body and can cause death), increased levels of certain white blood cells (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g., rash, itching, difficulty breathing, wheezing, low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, drowsiness, vision disturbance, increased heart rate (tachycardia), dry mouth, stomach upset, abnormal liver function (this is more likely to occur in Japanese patients), sudden swelling of the skin and mucous membranes that can cause death (angioedema including fatal outcome), hives (urticaria), severe drug rash, joint pain (arthralgia), pain in the limbs, tendon pain, flu-like illness, increased levels of uric acid, liver enzymes, or creatine phosphokinase in the blood.
Very rare side effects (may affect up to 1 in 10,000 people):
Progressive scarring of lung tissue (interstitial lung disease)**
*This may have been an isolated case or related to an unknown mechanism.
**There have been reports of progressive scarring of lung tissue during treatment with telmisartan. However, it is not known whether telmisartan was the cause.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date refers to the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Telmisartan Teva Pharma
Appearance of the Product and Package Contents
Telmisartan Teva Pharma 40 mg tablets are white to off-white, oval-shaped tablets; one side of the tablet is engraved with the number "93". The other side of the tablet is engraved with the number "7459".
Telmisartan Teva Pharma is supplied in aluminum-aluminum peelable unit dose blisters and aluminum-aluminum unit dose blisters that contain 14x1, 28x1, 30x1, 40x1, 56x1, 60x1, 84x1, 90x1, 98x1, 100x1 tablets per blister pack, although only some pack sizes may be marketed.
Telmisartan Teva Pharma is also supplied in aluminum-aluminum blisters in packs of 28 and 30 tablets.
Please note that the instructions for removing the tablet from the blister strip are given on the outer carton of the peelable blisters.
Marketing Authorization Holder and Manufacturer
The marketing authorization holder is:
Teva B.V.
Swensweg 5
2031GA Haarlem
Netherlands
The manufacturer is:
TEVA Pharmaceutical Works Private Limited Company
H-4042 Debrecen,
Pallagi út 13,
Hungary
Or:
Pharmachemie B.V.
Swensweg 5,
2031 GA, Haarlem,
Netherlands
For more information about this medicinal product, please contact the local representative of the marketing authorization holder:
Belgium Teva Pharma Belgium N.V./S.A. AG Tel: +32 38207373 Bulgaria Pharmachemie Ltd. Tel: +359 24899585 | Lithuania UAB Teva Baltics Tel: +370 52660203 Luxembourg Teva Pharma Belgium N.V./S.A./AG Belgium Tél/Tel: +32 38207373 |
Czech Republic Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111 | Hungary Teva Gyógyszergyár Zrt. Tel.: +36 12886400 |
Denmark Teva Denmark A/S Tlf: +45 44985511 | Malta Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Germany TEVA GmbH Tel: +49 73140208 | Netherlands Teva Nederland B.V. Tel: +31 8000228400 |
Estonia UAB Teva Baltics Eesti filiaal Tel: +372 6610801 | Norway Teva Norway AS Tlf: 47 66775590 |
Greece Specifar A.B.E.E. Tel: +30 2118805000 | Austria ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070 |
Spain Teva Pharma, S.L.U Tél: +34 913873280 | Poland Teva Pharmaceuticals Polska Sp. z o.o. Tel.: +48 223459300 |
France Teva Santé Tél: +33 155917800 | Portugal Teva Pharma - Produtos Farmacêuticos, Lda Tel: +351 214235910 |
Croatia Pliva Hrvatska d.o.o. Tel: +385 13720000 | Romania Teva Pharmaceuticals S.R.L. Tel: +40 212306524 |
Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407117 | Slovenia Pliva Ljubljana d.o.o. Tel: +386 15890390 |
Iceland Teva Pharma Iceland ehf. Sími: +354 5503300 | Slovakia TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911 |
Italy Teva Italia S.r.l. Tel: +39 028917981 | Finland Teva Finland Oy Puh/Tel: +358 201805900 |
Cyprus Specifar A.B.E.E. Greece Tel: +30 2118805000 | Sweden Teva Sweden AB Tel: +46 42121100 |
Latvia UAB Teva Baltics filiale Latvija Tel: +371 67323666 | United Kingdom (Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Date of Last Revision of this Leaflet:{month/YYYY}.
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/.